d'Ettorre G - Search Results

1

A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients.

Ciccullo A, Baldin G, Capetti A, Rusconi S, Sterrantino G, d'Ettorre G, Colafigli M, Modica S, Lagi F, Giacomelli A, Cossu MV, Restelli S, De Luca A, Di Giambenedetto S. Ciccullo A, et al. Antivir Ther. 2019;24(1):63-67. doi: 10.3851/IMP3270. Antivir Ther. 2019. PMID: 30277466

2

Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.

Nicastri E, Sarmati L, d'Ettorre G, Palmisano L, Parisi SG, Uccella I, Rianda A, Concia E, Vullo V, Vella S, Andreoni M. Nicastri E, et al. J Med Virol. 2003 Jan;69(1):1-6. doi: 10.1002/jmv.10269. J Med Virol. 2003. PMID: 12436471

3

Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens.

Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Andreoni C, Dori L, Gatti F, Montano M, Buonomini AR, Boldrin C, Palù G, Vullo V, Andreoni M. Sarmati L, et al. J Med Virol. 2007 Jul;79(7):880-6. doi: 10.1002/jmv.20914. J Med Virol. 2007. PMID: 17516532 Clinical Trial.

4

Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up.

d'Ettorre G, Zaffiri L, Ceccarelli G, Andreotti M, Massetti AP, Vella S, Mastroianni CM, Vullo V. d'Ettorre G, et al. HIV Clin Trials. 2007 May-Jun;8(3):182-8. doi: 10.1310/hct0803-182. HIV Clin Trials. 2007. PMID: 17621465 Clinical Trial.

5

Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.

Skowron G, Spritzler JG, Weidler J, Robbins GK, Johnson VA, Chan ES, Asmuth DM, Gandhi RT, Lie Y, Bates M, Pollard RB; NIH/NIAID ACTG 384 Protocol Team and Monogram Biosciences. Skowron G, et al. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):250-8. doi: 10.1097/QAI.0b013e3181938faf. J Acquir Immune Defic Syndr. 2009. PMID: 19194319 Free PMC article. Clinical Trial.

6

Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction.

Fabbiani M, Di Giambenedetto S, Ragazzoni E, D'Ettorre G, Parruti G, Prosperi M, Bracciale L, Cauda R, Navarra P, De Luca A. Fabbiani M, et al. Pharmacol Res. 2011 Mar;63(3):249-53. doi: 10.1016/j.phrs.2010.11.009. Epub 2010 Dec 2. Pharmacol Res. 2011. PMID: 21130167

7

Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy.

d'Ettorre G, Forcina G, Ceccarelli G, Andreotti M, Andreoni C, Rizza C, Massetti AP, Sarmati L, Mastroianni CM, Vella S, Andreoni M, Vullo V. d'Ettorre G, et al. J Chemother. 2011 Feb;23(1):24-7. doi: 10.1179/joc.2011.23.1.24. J Chemother. 2011. PMID: 21482490

8

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease.

Esposito A, Floridia M, d'Ettorre G, Pastori D, Fantauzzi A, Massetti P, Ceccarelli G, Ajassa C, Vullo V, Mezzaroma I. Esposito A, et al. BMC Infect Dis. 2011 Dec 14;11:341. doi: 10.1186/1471-2334-11-341. BMC Infect Dis. 2011. PMID: 22166160 Free PMC article.

9

Kidney disease in HIV-infected patients.

Scarpino M, Pinzone MR, Di Rosa M, Madeddu G, Focà E, Martellotta F, Schioppa O, Ceccarelli G, Celesia BM, d'Ettorre G, Vullo V, Berretta S, Cacopardo B, Nunnari G. Scarpino M, et al. Eur Rev Med Pharmacol Sci. 2013 Oct;17(19):2660-7. Eur Rev Med Pharmacol Sci. 2013. PMID: 24142615 Free article. Review.

10

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study).

Fabbiani M, Mondi A, Colafigli M, D'Ettorre G, Paoletti F, D'Avino A, Ciccarelli N, Sidella L, Murri R, Fortuna S, Vullo V, Cauda R, De Luca A, Di Giambenedetto S. Fabbiani M, et al. Scand J Infect Dis. 2014 Jan;46(1):34-45. doi: 10.3109/00365548.2013.840920. Epub 2013 Oct 28. Scand J Infect Dis. 2014. PMID: 24161018 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters